AU509313B2 – Clavulanic acid
– Google Patents
AU509313B2 – Clavulanic acid
– Google Patents
Clavulanic acid
Info
Publication number
AU509313B2
AU509313B2
AU10891/76A
AU1089176A
AU509313B2
AU 509313 B2
AU509313 B2
AU 509313B2
AU 10891/76 A
AU10891/76 A
AU 10891/76A
AU 1089176 A
AU1089176 A
AU 1089176A
AU 509313 B2
AU509313 B2
AU 509313B2
Authority
AU
Australia
Prior art keywords
clavulanic acid
clavulanic
acid
Prior art date
1975-02-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU10891/76A
Other versions
AU1089176A
(en
Inventor
ID. Noble D. Noble. H. M. and Wall W. F Fleming
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1975-02-07
Filing date
1976-02-06
Publication date
1980-05-08
1975-02-07
Priority claimed from GB540975A
external-priority
patent/GB1543563A/en
1976-02-06
Application filed by Glaxo Laboratories Ltd
filed
Critical
Glaxo Laboratories Ltd
1977-08-11
Publication of AU1089176A
publication
Critical
patent/AU1089176A/en
1980-05-08
Application granted
granted
Critical
1980-05-08
Publication of AU509313B2
publication
Critical
patent/AU509313B2/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
AU10891/76A
1975-02-07
1976-02-06
Clavulanic acid
Expired
AU509313B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
GB540975A
GB1543563A
(en)
1975-02-07
1975-02-07
Beta-lactam antibiotic in purified form
GBGB5,409/75
1975-02-07
GB1107675
1975-03-17
JPJP11,076/7
1975-03-17
Publications (2)
Publication Number
Publication Date
AU1089176A
AU1089176A
(en)
1977-08-11
AU509313B2
true
AU509313B2
(en)
1980-05-08
Family
ID=26239868
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU10891/76A
Expired
AU509313B2
(en)
1975-02-07
1976-02-06
Clavulanic acid
Country Status (15)
Country
Link
US
(3)
US4490294A
(en)
JP
(2)
JPS51101994A
(en)
AT
(1)
AT353409B
(en)
AU
(1)
AU509313B2
(en)
CH
(1)
CH624956A5
(en)
DE
(1)
DE2604697A1
(en)
DK
(1)
DK141099B
(en)
ES
(1)
ES444948A1
(en)
FI
(1)
FI63580C
(en)
FR
(1)
FR2368276A1
(en)
IE
(1)
IE43790B1
(en)
IT
(2)
IT1059403B
(en)
NL
(1)
NL7601227A
(en)
SE
(1)
SE421796B
(en)
YU
(1)
YU40452B
(en)
Families Citing this family (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
NZ177159A
(en)
*
1974-04-20
1978-03-06
Beecham Group Ltd
Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
GB1542405A
(en)
*
1975-04-15
1979-03-21
Beecham Group Ltd
Clavulanic acid derivatives
EP0002370B1
(en)
*
1977-12-02
1983-05-11
Beecham Group Plc
A process for the preparation of ether derivatives of clavulanic acid
EP0026044B1
(en)
*
1979-08-24
1983-06-08
Beecham Group Plc
Amine salt of clavulanic acid, its preparation and use
GB9702216D0
(en)
*
1997-02-04
1997-03-26
Smithkline Beecham Plc
Novel product
GB9702218D0
(en)
*
1997-02-04
1997-03-26
Smithkline Beecham Plc
Novel product
EP0867515B1
(en)
*
1997-03-24
1999-12-08
CIPAN-Companhia Industrial Produtora De Antibioticos, S.A.
Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid
JPH11254368A
(en)
*
1998-03-12
1999-09-21
Central Motor Co Ltd
Member retainer
EP1097238A1
(en)
*
1998-07-03
2001-05-09
Dsm N.V.
Fermentation process to produce clavulanic acid at a low concentration of free amino acids
PT102181A
(en)
*
1998-07-20
2000-01-31
Dsm Nv
IMPROVED PROCESS FOR THE PRODUCTION OF CLAVULANIC ACID
HU0400913A2
(en)
*
2000-10-05
2006-11-28
Biogal Gyogyszergyar
Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
US20040072815A1
(en)
*
2002-02-12
2004-04-15
Koppel Gary A.
Antibiotic composition and method
KR100461278B1
(en)
*
2002-10-23
2004-12-10
현대자동차주식회사
Location and ejecting apparatus for welding parts of vehicle
EP3692159A1
(en)
2017-10-02
2020-08-12
Metabolic Explorer
Method for producing organic acid salts from fermentation broth
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
BE754693A
(en)
*
1969-08-12
1971-02-11
Lilly Co Eli
NEW ANTIBIOTIC AND PROCESS FOR PREPARING IT
NZ177159A
(en)
*
1974-04-20
1978-03-06
Beecham Group Ltd
Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
JO984B1
(en)
*
1977-10-11
1979-12-01
بيتشام غروب ليمتد
K-clavulanate/tri hydrate formulations
1976
1976-02-06
DK
DK49876AA
patent/DK141099B/en
not_active
IP Right Cessation
1976-02-06
YU
YU290/76A
patent/YU40452B/en
unknown
1976-02-06
IE
IE245/76A
patent/IE43790B1/en
unknown
1976-02-06
CH
CH148776A
patent/CH624956A5/en
not_active
IP Right Cessation
1976-02-06
AU
AU10891/76A
patent/AU509313B2/en
not_active
Expired
1976-02-06
JP
JP51012156A
patent/JPS51101994A/ja
active
Pending
1976-02-06
FI
FI760285A
patent/FI63580C/en
not_active
IP Right Cessation
1976-02-06
IT
IT7647988A
patent/IT1059403B/en
active
Protection Beyond IP Right Term
1976-02-06
NL
NL7601227A
patent/NL7601227A/en
active
Search and Examination
1976-02-06
ES
ES76444948A
patent/ES444948A1/en
not_active
Expired
1976-02-06
DE
DE19762604697
patent/DE2604697A1/en
active
Granted
1976-02-06
FR
FR7603281A
patent/FR2368276A1/en
active
Granted
1976-02-06
AT
AT83476A
patent/AT353409B/en
not_active
IP Right Cessation
1976-02-06
SE
SE7601337A
patent/SE421796B/en
not_active
IP Right Cessation
1976-02-09
IT
IT7648002A
patent/IT1066098B/en
active
1978
1978-03-20
US
US05/888,496
patent/US4490294A/en
not_active
Expired – Lifetime
1980
1980-05-07
US
US06/147,614
patent/US4367175A/en
not_active
Expired – Lifetime
1980-05-07
US
US06/147,584
patent/US4490295A/en
not_active
Expired – Lifetime
1989
1989-02-27
JP
JP1046384A
patent/JPH0222281A/en
active
Pending
Also Published As
Publication number
Publication date
US4367175A
(en)
1983-01-04
US4490295A
(en)
1984-12-25
IT1059403B
(en)
1982-05-31
DK49876A
(en)
1976-08-08
IE43790L
(en)
1976-08-07
YU29076A
(en)
1982-08-31
AU1089176A
(en)
1977-08-11
NL7601227A
(en)
1976-08-10
DE2604697C2
(en)
1992-10-29
FI63580C
(en)
1983-07-11
JPH0222281A
(en)
1990-01-25
IE43790B1
(en)
1981-06-03
US4490294A
(en)
1984-12-25
FR2368276A1
(en)
1978-05-19
FR2368276B1
(en)
1979-03-16
AT353409B
(en)
1979-11-12
ATA83476A
(en)
1979-04-15
JPS51101994A
(en)
1976-09-08
SE7601337L
(en)
1976-11-03
DK141099B
(en)
1980-01-14
FI63580B
(en)
1983-03-31
FI760285A
(en)
1976-08-08
SE421796B
(en)
1982-02-01
CH624956A5
(en)
1981-08-31
ES444948A1
(en)
1977-08-16
DE2604697A1
(en)
1976-08-19
IT1066098B
(en)
1985-03-04
DK141099C
(en)
1980-07-21
YU40452B
(en)
1986-02-28
Similar Documents
Publication
Publication Date
Title
AU503442B2
(en)
1979-09-06
Structural elements
AU1108376A
(en)
1977-08-18
Polyhemoglobin
AU1006976A
(en)
1977-07-14
Inhilator
AU1025376A
(en)
1977-07-21
Pourer-stopper
AU1230276A
(en)
1977-09-29
Amidinoureas
AU511853B2
(en)
1980-09-11
l-Phenyl-2-Oxo-Pyrroliaine-4-carboxylic acid derivatives
AU1230176A
(en)
1977-09-29
Imidinoureas
AU503489B2
(en)
1979-09-06
Substituted aminodeoxy clavulanic acid
AU503529B2
(en)
1979-09-06
Clavulanic acid
AU501066B2
(en)
1979-06-07
Fudidic acid derivatives
AU509313B2
(en)
1980-05-08
Clavulanic acid
AU1128976A
(en)
1977-09-01
Magneto-alternator
AU497932B2
(en)
1979-01-25
Phenoxyalkylcarboxylic acid derivatives
AU500761B2
(en)
1979-05-31
Phenoxyalkylcarboxylic acid derivatives
AU515736B2
(en)
1981-04-30
Clavulanic acid derivatives
AU508264B2
(en)
1980-03-13
Penicillins
HK48983A
(en)
1983-11-04
Clavulanic acid derivatives
AU500339B2
(en)
1979-05-17
Penicillins
AU517920B2
(en)
1981-09-03
Clavulanic acid derivatives
GB1547169A
(en)
1979-06-06
Clavulanic acid derivatives
AU1855676A
(en)
1978-04-20
Clavulanic acid derivatives
AU1191776A
(en)
1977-09-15
Fluoro-prostaglandins
AU500980B2
(en)
1979-06-07
Oxanilic acid derivatives
AU497577B2
(en)
1978-12-21
Clavulanic acid derivatives
AU497089B2
(en)
1978-11-30
Clavulanic acid
None